In preparation for its first MS therapy, OCREVUS, Genentech wanted to showcase its dedication to MS by launching a patient-centric digital campaign ahead of the launch. MS Voice was created to empower patients to share their experiences with the disease and engage with other patients. Given the competitive landscape, the campaign had to be game-changing to stand out and build trust across a wide range of patient and HCP audiences.
Details
Role
Research revealed a unique opportunity to engage active patients online and through social media. Given the target demographic’s wide age range, Facebook emerged as the best platform for delivering meaningful information and engaging them at pivotal moments in their treatment journey.
The creative strategy amplified MS patients’ voices, positioning them as heroes through a bold visual identity. Building on the campaign’s tone, the unbranded website served as a primary conduit to social media channels.
Facebook served as the core of a broader ecosystem, complemented by a YouTube channel and other digital channels, to expand Genentech’s footprint in the MS market.
The patient community received emails promoting live meet-up events nationwide to deepen connections and boost program participation.